Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 3
1996 6
1997 6
1998 6
1999 10
2000 7
2001 6
2002 6
2003 4
2004 6
2005 7
2006 6
2007 9
2008 12
2009 13
2010 13
2011 12
2012 14
2013 16
2014 13
2015 17
2016 18
2017 13
2018 11
2019 16
2020 19
2021 18
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

271 results
Results by year
Filters applied: . Clear all
Page 1
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields.
Moretta A, Scieuzo C, Petrone AM, Salvia R, Manniello MD, Franco A, Lucchetti D, Vassallo A, Vogel H, Sgambato A, Falabella P. Moretta A, et al. Among authors: sgambato a. Front Cell Infect Microbiol. 2021 Jun 14;11:668632. doi: 10.3389/fcimb.2021.668632. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34195099 Free PMC article. Review.
CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia.
D'Arena G, Vitale C, Coscia M, Lamorte D, Pietrantuono G, Perutelli F, D'Auria F, Statuto T, Valvano L, Tomasso A, Griggio V, Jones R, Mansueto G, Villani O, D'Agostino S, Viglioglia V, De Feo V, Calapai F, Mannucci C, Sgambato A, Efremov DG, Laurenti L. D'Arena G, et al. Among authors: sgambato a. Cancers (Basel). 2021 Aug 23;13(16):4239. doi: 10.3390/cancers13164239. Cancers (Basel). 2021. PMID: 34439393 Free PMC article.
Overcoming Resistance to EGFR Inhibitors in NSCLC.
Maione P, Sacco PC, Casaluce F, Sgambato A, Santabarbara G, Rossi A, Gridelli C. Maione P, et al. Among authors: sgambato a. Rev Recent Clin Trials. 2016;11(2):99-105. doi: 10.2174/1574887111666160330120431. Rev Recent Clin Trials. 2016. PMID: 27028971 Review.
Lung cancer, elderly and immune checkpoint inhibitors.
Casaluce F, Sgambato A, Maione P, Spagnuolo A, Gridelli C. Casaluce F, et al. Among authors: sgambato a. J Thorac Dis. 2018 May;10(Suppl 13):S1474-S1481. doi: 10.21037/jtd.2018.05.90. J Thorac Dis. 2018. PMID: 29951299 Free PMC article. Review.
ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLC.
Casaluce F, Sgambato A, Maione P, Rossi A, Ferrara C, Napolitano A, Palazzolo G, Ciardiello F, Gridelli C. Casaluce F, et al. Among authors: sgambato a. Target Oncol. 2013 Mar;8(1):55-67. doi: 10.1007/s11523-012-0250-9. Epub 2013 Jan 17. Target Oncol. 2013. PMID: 23325296 Review.
Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects.
Makaremi S, Asadzadeh Z, Hemmat N, Baghbanzadeh A, Sgambato A, Ghorbaninezhad F, Safarpour H, Argentiero A, Brunetti O, Bernardini R, Silvestris N, Baradaran B. Makaremi S, et al. Among authors: sgambato a. Biomedicines. 2021 Aug 24;9(9):1075. doi: 10.3390/biomedicines9091075. Biomedicines. 2021. PMID: 34572263 Free PMC article. Review.
CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance.
D'Arena G, De Feo V, Pietrantuono G, Seneca E, Mansueto G, Villani O, La Rocca F, D'Auria F, Statuto T, Valvano L, Arruga F, Deaglio S, Efremov DG, Sgambato A, Laurenti L. D'Arena G, et al. Among authors: sgambato a. Front Oncol. 2020 Nov 26;10:584427. doi: 10.3389/fonc.2020.584427. eCollection 2020. Front Oncol. 2020. PMID: 33324560 Free PMC article. Review.
New molecular targets in the treatment of NSCLC.
Schettino C, Bareschino MA, Sacco PC, Maione P, Rossi A, Casaluce F, Sgambato A, Gridelli C. Schettino C, et al. Among authors: sgambato a. Curr Pharm Des. 2013;19(30):5333-43. doi: 10.2174/13816128113199990343. Curr Pharm Des. 2013. PMID: 23394083 Review.
271 results